BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3334663)

  • 1. Comparative in vitro activity of imipenem, the first thienamycin antibiotic: a review of a multi-center study.
    Satta G; Carlone N; Chiarini A; Cocuzza G; Covelli I; Falcone G; Campa M; Fontana R; Garaci E; Dainelli B
    Chemioterapia; 1987 Jun; 6(2 Suppl):69-71. PubMed ID: 3334663
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates.
    Bastianini L; Sposini T; Bartoli A; Marconi P
    Microbiologica; 1988 Apr; 11(2):137-42. PubMed ID: 3165489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility survey of piperacillin/tazobactam and some beta-lactam comparators in Italy.
    Stefani S; Bonfiglio G; Bianchi C; Zollo A; Nicoletti G
    Drugs Exp Clin Res; 1998; 24(2):105-13. PubMed ID: 9675551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activity of imipenem and nine other antimicrobials against recently isolated pathogens.
    Bonadio M; Maccanti O; Cosci S; Giordani R
    J Chemother; 1989 Jul; 1(4 Suppl):58-60. PubMed ID: 16312303
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
    Klietmann W; Focht J; Nösner K
    Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro evaluation of the antibiotic effect of imipenen on bacterial strains isolated mostly from compromised patients].
    Bartolucci M; Galluzzi F; Sanchioni G; Aureli G
    Quad Sclavo Diagn; 1988; 24(1-4):203-12. PubMed ID: 3268913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro study of the antibacterial effect of cefotetan against gram-positive and gram-negative aerobic and anaerobic strains from fresh clinical isolates.
    Klietmann W; Focht J; Nösner K
    Chemioterapia; 1987 Jun; 6(2 Suppl):92-3. PubMed ID: 3509542
    [No Abstract]   [Full Text] [Related]  

  • 8. The identity and in vitro antibiotic sensitivity of aerobic gram-negative rods in a community hospital.
    Ellenbogen C; Hester SC
    N C Med J; 1984 Jan; 45(1):19-22. PubMed ID: 6583511
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current state of antibiotic resistance of pathogenic aerobic bacteria in Hungary].
    Konkoly T; Marianne ; Bán E
    Orv Hetil; 1986 Apr; 127(17):995-1001. PubMed ID: 3703555
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urinary infection. II. Comparative in vitro activities of several antibiotic drugs against Gram-positive bacteria].
    Allocco A; Giachino F; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
    G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):68-78. PubMed ID: 7498618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of imipenem against gram-positive anaerobic bacteria.
    Dubreuil L; Devos J; Romond C
    Int J Clin Pharmacol Res; 1987; 7(1):39-43. PubMed ID: 3473047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study.
    Bouchillon SK; Hoban DJ; Johnson JL; Johnson BM; Butler DL; Saunders KA; Miller LA; Poupard JA
    Int J Antimicrob Agents; 2004 Feb; 23(2):181-96. PubMed ID: 15013045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibilities of common gram negative bacilli to aminoglycosides and cephalosporins.
    Patamasucon P; Kalnauwakul S; Ratamaruesa A; Silpapojakul K
    J Med Assoc Thai; 1987 Sep; 70(9):511-5. PubMed ID: 3681179
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
    Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
    G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The postantibiotic effect (PAE) of the new penem FCE 22101 on gram-positive and -negative bacteria in vitro and in vivo.
    Bergholm AM; Dornbusch K
    J Chemother; 1989 Jul; 1(4 Suppl):64-6. PubMed ID: 16312306
    [No Abstract]   [Full Text] [Related]  

  • 16. Investigation of the antibiotic susceptibility patterns of pathogens causing nosocomial infections.
    Yaman A; Tasova Y; Kibar F; Inal AS; Saltoglu N; Buyukcelik O; Kurtaran B; Dundar IH
    Saudi Med J; 2004 Oct; 25(10):1403-9. PubMed ID: 15494811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.
    Raja NS
    J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitivity of nonfermenting gram-negative bacteria of clinical origin to antibacterial preparations].
    Shchenderov BA; Serkova GP; Tiurin MV
    Antibiotiki; 1984 Mar; 29(3):191-5. PubMed ID: 6732205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteria.
    Giacometti A; Cirioni O; Greganti G; Quarta M; Scalise G
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3320-4. PubMed ID: 9835539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence and antibiotic-sensitivity of gram-negative bacteria in the urinary infections (author's transl)].
    Lechi A; Arosio E; Pancera P; Montesi G; Mengoli C; Biscardo G; Bonomi U
    Quad Sclavo Diagn; 1980 Sep; 16(3):282-7. PubMed ID: 7244101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.